HealthLynked (OTCQB:HLYK) Corp has announced that an enhanced version of its female technology (FemTech) app Oohvie is now available to all users as the company positions itself to capitalize on growth trends in the FemTech industry.
The company said the newly released version of its women’s health and wellbeing app allows users to live chat with a nurse to answer their medical questions and order feminine products at low cost which are sent directly to their homes.
The app already allowed users to track their menstrual cycle moods, symptoms, weight, activities and other factors specific to women’s health.
READ: HealthLynked reports annual revenue growth of 50% to $9.2M
It uniquely features the ability to connect users with their healthcare providers, which HealthLynked said improves the patient evaluation process.
HealthLynked CEO Michael Dent said that with Oohvie, the company was strategically positioned to take advantage of the projected rapid growth in the FemTech market which is projected to reach $60 billion by 2027.
“We expect this app will be a major contributor to the growth of our revenue over the next five years as well as our digital healthcare network,” Dent said.
“We plan to intensify our marketing efforts over the next quarter as well as integrate Oohvie into our established core HealthLynked app, allowing users to share information with their doctors to enhance women's health and wellness."
Practice manager of HealthLynked’s Naples Women’s Center, Fiona Molloy, added that Oohvie has been a valuable tool to better manage the practice’s patients and their health.
“Patients can now share detailed information about their menstrual cycle and symptoms and Oohvie can help them achieve pregnancy based on the app’s ovulation prediction algorithm,” Molloy said.
Oohvie is available for download on iOS devices here and Android devices here.
HealthLynked is improving healthcare for patient members and healthcare providers through the efficient exchange of medical information via its cloud-based platform.
Contact Emily at emily.jarvie@proactiveinvestors.com
Follow her on Twitter @emilyjjarvie